In the intestinal mucosa of IBD patients, IL-22-producing CD4+ T cells appeared to be decreased in actively inflamed tissues [71,72], and cluster analysis highlighted that the IL-22-producing T cell population should be considered independently from the Th17 and Th1 subsets [73]. This evidence concerns the gene IL22 and inflammatory bowel disease.